This finding is consistent with BRCA1 c.5407-25T>A, playing a role in OC risk, as has been shown with LOH analyses of OC tumor DNA from carriers of BRCA1 pathogenic variants [45]. The gene discussed is BRCA1; the disease is neoplasm.